Learn more about the benefits and risks of taking Lovenox during pregnancy. While most pregnancies progress smoothly and without serious medical issues, pregnancy usually doesn’t come without some ...

Sanofi-Aventis said US sales of anti-thrombotic Lovenox were cut nearly in half by the launch of generic competition, an indication hospitals are showing little hesitation in using the copycat version ...

LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...

Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the kidneys. To determine whether this characteristic heightens bleeding risk in ...

(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...

Sanofi-Aventis is suing FDA, claiming the agency acted inconsistently and unlawfully in approving a generic version of its anticoagulant Lovenox. The approval of the generic, developed by Momenta ...

Sanofi-Aventis has suffered a major blow in the USA with the news that a California court has invalidated the patent on its top-selling antithrombotic Lovenox, an announcement which has sent its ...

Sanofi SA (NYSE: SNY) said in a letter sent to customers dated Nov. 30 that it has discontinued selling the Authorized Generic version of Lovenox (Enoxaparin). We note that Sanofi's decision to ...

Hospitals, third-party payors, and people without insurance who indirectly purchased, paid for, and/or reimbursed some or all of the purchase price for Lovenox® or generic enoxaparin; In Arizona, ...

Reporting from Washington — In a closely watched decision, the Food and Drug Administration on Friday approved an application by German drug maker Sandoz and Momenta Pharmaceuticals Inc. of Cambridge, ...